Decreased outer membrane permeability protects mycobacteria from killing by ubiquitin-derived peptides

Authors

  • Georgiana E. Purdy,

    Corresponding author
    1. Department of Microbiology and Immunology, Cornell University, College of Veterinary Medicine, Ithaca, NY 14853, USA.
      *E-mail purdyg@ohsu.edu; Tel. (+1) 503 346 0767; Fax (+1) 503 494 6862.
    Search for more papers by this author
    • Present address: Molecular Microbiology and Immunology, Mail Code L220, Oregon Health Sciences University, 3181 S.W. Sam Jackson Park Road, Portland, OR 97201-3098, USA.

  • Michael Niederweis,

    1. Department of Microbiology, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
    Search for more papers by this author
  • David G. Russell

    1. Department of Microbiology and Immunology, Cornell University, College of Veterinary Medicine, Ithaca, NY 14853, USA.
    Search for more papers by this author

*E-mail purdyg@ohsu.edu; Tel. (+1) 503 346 0767; Fax (+1) 503 494 6862.

Summary

Ubiquitin-derived peptides are bactericidal in vitro and contribute to the mycobactericidal activity of the lysosome. To further define interactions of ubiquitin-derived peptides with mycobacteria, we screened for mutants with increased resistance to the bactericidal activity of the synthetic ubiquitin-derived peptide Ub2. The four Ub2-resistant Mycobacterium smegmatis mutants were also resistant to the bactericidal action of other antimicrobial peptides and macrophages. Two mutants were in the mspA gene encoding the main M. smegmatis porin. Using a translocation-deficient MspA point mutant, we showed that susceptibility of M. smegmatis to Ub2 was independent of MspA channel activity. Instead, the M. smegmatis Ub2-resistant mutants shared a common phenotype of decreased cell wall permeability compared with wild-type bacteria. Expression of mspA rendered Mycobacterium tuberculosis CDC1551 more susceptible both to ubiquitin-derived peptides in vitro and to lysosomal killing in macrophages. Finally, biochemical assays designed to assess membrane integrity indicated that Ub2 treatment impairs membrane function of M. smegmatis and M. tuberculosis cells. The M. smegmatis Ub2-resistant mutants were more resistant than wild-type M. smegmatis to this damage. We conclude that Ub2 targets mycobacterial membranes and that reduced membrane permeability provides mycobacteria intrinsic resistance against antimicrobial compounds including bactericidal ubiquitin-derived peptides.

Ancillary